SCHEMBL12434232

SCHEMBL12434232

CCc1cc(C)nc2c1[nH]c(=O)n2C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR1E P28566 1/20 0.44
CHRNA3 P32297 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
OPRM1 P35372 1/20 0.44
OPRK1 P41145 1/20 0.44
ALDH1A1 P00352 3/20 0.39
TSHR P16473 2/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
PABPC1 P11940 1/20 0.38
POLB P06746 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2267443 0.76 CHRNB2 (0.43) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A
SCHEMBL2268013 0.66 KDM4E (0.59) ALDH1A1TSHRKMT2AMEN1LMNA
SCHEMBL23240567 0.66 KMT2A (0.39) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A
SCHEMBL7885985 0.66 RXFP1 (0.55) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A
SCHEMBL17813483 0.65 LMNA (0.45) ALDH1A1TSHRKMT2AMEN1LMNA
SCHEMBL11160869 0.64 LMNA (0.59) TSHRKMT2AMEN1LMNAPABPC1
SCHEMBL387339 0.63 ALDH1A1 (0.54) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A
SCHEMBL8226758 0.63 CHRNB2 (0.39) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A
SCHEMBL23103463 0.63 CHEK1 (0.35) ALDH1A1TSHRLMNAGAAHSD17B10
SCHEMBL16221674 0.62 HTT (0.40) CHRNB2ADRA1DHTR1ECHRNA3ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011092293-A2 CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2011-08-04 WO disclosed